Rheumatology and Therapy,
Journal Year:
2023,
Volume and Issue:
11(1), P. 79 - 96
Published: Nov. 19, 2023
Current
therapies
for
autoimmune
rheumatic
diseases
(ARDs)
have
limited
efficacy
in
certain
patients,
highlighting
the
need
development
of
novel
treatment
approaches.
This
meta-analysis
aims
to
assess
and
safety
low-dose
interleukin-2
(LD-IL-2)
evaluate
alterations
lymphocyte
subsets
various
following
administration
different
dosages
LD-IL-2.
A
comprehensive
search
was
conducted
PubMed,
Web
Science,
Cochrane
Library,
Embase
databases
CNKI
identify
relevant
studies.
total
31
trials
were
included
this
meta-analysis.
The
review
protocols
registered
on
PROSPERO
(CRD42022318916),
study
followed
PRISMA
guidelines.
Following
LD-IL-2
treatment,
patients
with
ARDs
exhibited
a
significant
increase
number
Th17
cells
Tregs
compared
their
pre-treatment
levels
[standardized
mean
difference
(SMD)
=
0.50,
95%
confidence
interval
(CI)
(0.33,
0.67),
P
<
0.001;
SMD
1.13,
CI
(0.97,
1.29),
0.001].
Moreover,
Th17/Tregs
ratio
showed
decrease
[SMD
−
0.54,
(−
0.64,
0.45),
In
rheumatoid
arthritis
(RA)
systemic
lupus
erythematosus
(SLE),
injection
led
Treg
numbers,
disease
activity
scores,
including
Disease
Activity
Score-28
joints
(DAS28),
Systemic
Lupus
Erythematosus
Index
(SELENA-SLEDAI)
Cutaneous
Dermatomyositis
Area
Severity
(CDASI),
all
significantly
reduced.
No
serious
adverse
events
reported
any
Additionally,
54.8%
nephritis
achieved
distinct
clinical
remission
treatment.
Injection
site
reactions
fever
most
common
side
effects
LD-IL-2,
occurring
33.1%
14.4%
respectively.
promise
well
tolerated
management
ARDs,
as
it
effectively
promoted
proliferation
functional
recovery
Tregs.
Retrospectively
(CRD42022318916,
21/04/2022).
Cells,
Journal Year:
2025,
Volume and Issue:
14(8), P. 560 - 560
Published: April 8, 2025
Chronic
inflammation
and
autoimmune
diseases
are
driven,
in
part,
by
the
activation
of
(auto)reactive
CD4+
T-cells,
highlighting
their
potential
as
therapeutic
targets
for
these
diseases.
Nicotinamide
(NAM)
has
demonstrated
anti-inflammatory
properties
various
disease
models
already
safety
several
large
clinical
trials
humans.
The
mechanisms
behind
observations,
especially
direct
effects
on
remain
poorly
understood.
Here,
we
address
this
gap
investigating
how
NAM
influences
T-cell
function.
We
also
describe
that
treatment
significantly
suppresses
vitro,
evidenced
impaired
proliferation
reduced
expression
surface
markers.
Additionally,
resulted
production
pro-inflammatory
cytokines,
IL-2,
IFNy,
IL-17,
further
its
potential.
found
modulates
key
metabolic
processes,
including
glycolysis
reactive
oxygen
species
(ROS)
production—both
essential
to
activation.
Taken
together,
our
findings
provide
novel
mechanistic
insight
into
regulation
NAM,
suggesting
an
attractive
candidate
therapies
targeting
immune-related
Frontiers in Molecular Biosciences,
Journal Year:
2025,
Volume and Issue:
12
Published: April 14, 2025
Objectives
Systemic
Lupus
Erythematosus
(SLE)
is
a
highly
heterogeneous
autoimmune
disease
with
complex
pathogenic
mechanisms.
Mitochondrial
function
and
programmed
cell
death
(PCD)
play
important
roles
in
SLE.
This
study
aims
to
screen
biomarkers
related
mitochondrial
SLE
analyze
their
underlying
Methods
SLE-related
databases
were
derived
from
the
GEO
database,
where
three
merged
into
one
database
as
training
set.
Genes
PCD
sourced
MitoCarta
3.0
database.
Key
genes
identified
through
bioinformatics
machine
learning,
expression
levels
diagnostic
efficacy
validated
using
two
datasets
validation
The
relationship
between
immune
cells
was
analyzed
CIBERSORT
infiltration
analysis.
Diagnostic
genes-related
miRNAs
predicted
online
databases.
Differential
circRNAs
screened
circRNA
datasets,
circbank,
finally
constructing
circRNA-miRNA-mRNA
ceRNA
regulatory
network.
Results
From
448
differential
set,
key
genes,
IFI27
LAMP3,
learning
WGCNA.
Enrichment
analysis
revealed
that
they
mainly
enriched
pathways
such
cycle,
systemic
lupus
erythematosus,
cytosolic
DNA
sensing
pathway,
toll-like
receptor
(TLR)
signaling
pathway
nod-like
(NLR)
pathway.
Immune
found
compared
normal
group,
11
differentially
expressed,
9
types
of
LAMP3
10
cells.
final
constructed
network
consists
2
mRNAs,
5
miRNAs,
4
circRNAs.
Conclusion
Our
ultimately
(IFI27
LAMP3)
an
role
In
future,
have
potential
become
diagnosis
treatment
Their
response
may
provide
new
strategies
for
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Sept. 5, 2023
Background
Lupus
nephritis
(LN)
constitutes
the
most
severe
organ
manifestations
of
systemic
lupus
erythematosus
(SLE),
where
pathogenic
T
cells
have
been
identified
to
play
an
essential
role
in
‘helping’
B
make
autoantibodies
and
produce
inflammatory
cytokines
that
drive
kidney
injury
SLE.
Regulatory
(Tregs),
responsible
for
decreasing
inflammation,
are
defective
decreased
SLE
associated
with
disease
progression.
We
hypothesize
treatment
allogeneic,
healthy
Tregs
derived
from
umbilical
cord
blood
(UCB)
may
arrest
such
process
protect
against
damage.
Methods
UCB-Tregs
function
was
examined
by
their
ability
suppress
CellTrace
Violet-labeled
peripheral
mononuclear
(PBMCs)
or
donor
(HD)
conventional
(Tcons);
inhibiting
secretion
PBMCs.
Humanized
model
established
female
Rag2
-/-
γc
mice
were
transplanted
3
×
10
6
human
SLE-PBMCs
intravenous
injection
on
day
0,
followed
single
multiple
understand
impact
development.
Mice
PB
assessed
weekly
flow
cytometry.
Phenotypic
analysis
isolated
mouse
PB,
lung,
spleen,
liver
performed
Kidney
damage
quantifying
urinary
albumin
creatinine
secretion.
Systemic
evaluated
anti-dsDNA
IgG
Ab
as
well
immunohistochemistry
organs.
inflammation
determined
measuring
cytokine
levels.
Results
In
vitro
,
able
HD
Tcons
a
similar
extent.
decrease
several
including
IFN-γ,
IP-10,
TNF-α,
IL-6,
IL-17A,
sCD40L
PBMCs
time-dependent
manner,
corresponding
increase
suppressor
cytokine,
IL-10.
vivo
doses
led
CD8
+
effector
different
organs
circulating
cytokines.
Improvement
skin
loss
hair;
resolution
CD3
CD20
Ki67
SLE-PBMC
infiltration
observed
UCB-Treg
recipients
plasma
anti-double
stranded
DNA
antibody
levels
improved
albuminuria.
Conclusions
can
burden
SLE,
reduce
auto-antibody
production
resolve
end
especially,
improve
function.
Adoptive
therapy
should
be
explored
clinical
setting.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(20), P. 10905 - 10905
Published: Oct. 10, 2024
Systemic
lupus
erythematosus
(SLE)
is
a
complex
autoimmune
disease,
characterized
by
considerable
changes
in
peripheral
lymphocyte
structure
and
function,
that
plays
critical
role
commencing
reviving
the
inflammatory
immune
signaling
pathways.
In
healthy
individuals,
B
lymphocytes
have
major
guiding
directing
defense
mechanisms
against
pathogens.
Certain
phenotype,
including
alterations
surface
endosomal
receptors,
occur
presence
of
SLE
lead
to
dysregulation
subpopulations.
Functional
are
loss
self-tolerance,
intra-
extrafollicular
activation,
increased
cytokine
autoantibody
production.
T
seem
supporting,
rather
than
leading,
disease
pathogenesis.
Substantial
aberrations
subsets
evident,
include
reduction
cytotoxic,
regulatory,
advanced
differentiated
subtypes,
together
with
an
increase
activated
autoreactive
forms
abnormalities
follicular
cells.
Up-regulated
subpopulations,
such
as
central
effector
memory
cells,
produce
pre-inflammatory
cytokines,
activate
lymphocytes,
stimulate
cell
This
review
explores
pivotal
roles
pathogenesis
Lupus
Nephritis,
emphasizing
multifaceted
interactions
their
phenotypic
functional
dysregulations.
BMC Immunology,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: Nov. 10, 2023
Abstract
Background
In
recent
years,
research
on
the
pathogenesis
of
systemic
lupus
erythematosus
(SLE)
has
made
great
progress.
However,
prognosis
disease
remains
poor,
and
high
sensitivity
accurate
biomarkers
are
particularly
important
for
early
diagnosis
SLE.
Methods
SLE
patient
information
was
acquired
from
three
Gene
Expression
Omnibus
(GEO)
databases
used
differential
gene
expression
analysis,
such
as
weighted
coexpression
network
(WGCNA)
functional
enrichment
analysis.
Subsequently,
algorithms,
random
forest
(RF),
support
vector
machine-recursive
feature
elimination
(SVM-REF)
least
absolute
shrinkage
selection
operation
(LASSO),
were
to
analyze
above
key
genes.
Furthermore,
levels
final
core
genes
in
peripheral
blood
patients
confirmed
by
real-time
quantitative
polymerase
chain
reaction
(RT-qPCR)
assay.
Results
Five
(ABCB1,
CD247,
DSC1,
KIR2DL3
MX2)
found
this
study.
Moreover,
these
had
good
reliability
validity,
which
further
clinical
samples
patients.
The
receiver
operating
characteristic
curves
(ROC)
five
also
revealed
that
they
critical
roles
Conclusion
summary,
obtained
validated
through
machine-learning
offering
a
new
perspective
molecular
mechanism
potential
therapeutic
targets
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 3, 2023
Systemic
lupus
erythematosus
is
a
debilitating
autoimmune
disease
characterized
by
uncontrolled
activation
of
adaptive
immunity,
particularly
B
cells,
which
predominantly
affects
women
in
9
to
1
ratio
compared
men.
This
stark
sex
disparity
strongly
suggests
role
for
female
hormones
the
disease’s
onset
and
progression.
Indeed,
it
widely
recognized
that
estradiol
not
only
enhances
survival
autoreactive
cells
but
also
stimulates
production
autoantibodies
associated
with
systemic
erythematosus,
such
as
anti-nuclear
antibodies
anti-dsDNA
antibodies.
Clinical
manifestations
typically
emerge
after
puberty
persist
throughout
reproductive
life.
Furthermore,
symptoms
often
exacerbate
during
premenstrual
period
pregnancy,
increased
levels
can
contribute
flares.
Despite
being
fertile,
face
heightened
risk
pregnancy-related
complications,
including
pregnancy
loss
stillbirth,
significantly
surpass
rates
observed
healthy
population.
Therefore,
this
review
aims
summarize
discuss
existing
literature
on
influence
B-cell
patients
particular
emphasis
their
impact
loss.
Journal of International Medical Research,
Journal Year:
2024,
Volume and Issue:
52(10)
Published: Oct. 1, 2024
Objective
This
study
aimed
to
evaluate
the
expression
status
of
miR-132-3p
in
CD4
+
T
cells
patients
with
systemic
lupus
erythematosus
(SLE)
and
explore
its
potential
role
SLE
development.
Methods
The
included
60
30
healthy
controls.
was
detected
by
real-time
quantitative
reverse
transcription
polymerase
chain.
Bioinformatics
analyses
were
employed
predict
target
genes
miR-132-3p.
associations
between
levels
Disease
Activity
Index
(SLEDAI)
score,
as
well
laboratory
characteristics,
analyzed.
Results
significantly
higher
compared
analysis
identified
FOXO1
a
gene
miR-132-3p,
particular
emphasis
on
FOXO
signaling
pathway.
up-regulation
associated
high
SLEDAI
anti-double-stranded
DNA
levels,
low
C3
C4
positive
anti-ribosomal
P,
24-hour
urinary
protein
SLE.
Conclusions
may
contribute
cell
dysregulation
during
targeting
could
potentially
be
used
assess
disease
severity.